|
HS Code |
403063 |
| Name | Pirenoxine Sodium |
| Chemical Formula | C12H8NNaO4S |
| Molecular Weight | 285.25 g/mol |
| Appearance | Yellowish powder |
| Solubility | Soluble in water |
| Pharmacological Class | Cataract inhibitor |
| Cas Number | 7276-11-7 |
| Application | Treatment of cataracts |
| Route Of Administration | Ophthalmic (eye drops) |
| Storage Conditions | Store in a cool, dry place and protect from light |
| Mechanism Of Action | Inhibits lens protein aggregation |
| Synonyms | Pirenoxin sodium; Catalin |
| Stability | Stable under recommended storage conditions |
| Ph Range | Usually between 6.0 and 7.5 in solutions |
| Contraindications | Known hypersensitivity to the drug |
As an accredited Pirenoxine Sodium factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White plastic bottle containing 5 grams of Pirenoxine Sodium, sealed with a tamper-evident cap and labeled with product and safety information. |
| Shipping | Pirenoxine Sodium is shipped in securely sealed, airtight containers to protect it from moisture and contamination. Packages are clearly labeled with hazard information and handled in accordance with chemical safety regulations. Temperature and storage conditions are maintained as specified, ensuring the product’s integrity during transit. Shipping complies with relevant international transport regulations. |
| Storage | Pirenoxine Sodium should be stored in a tightly closed container, protected from moisture and light. Keep it at room temperature, ideally between 15°C and 25°C (59°F–77°F). Avoid extreme heat or cold. Store the chemical in a dry, well-ventilated area, away from incompatible substances, and ensure that only authorized personnel have access to it. |
|
Purity 99%: Pirenoxine Sodium with purity 99% is used in ophthalmic formulations, where it ensures optimal clarity and minimal impurities for enhanced lens transparency. Molecular Weight 316.19 g/mol: Pirenoxine Sodium with molecular weight 316.19 g/mol is used in aqueous suspension eye drops, where it enables precise dosing and reproducible pharmacokinetics. Particle Size D90 < 10 μm: Pirenoxine Sodium with particle size D90 < 10 μm is used in sterile ophthalmic suspensions, where it provides improved suspension stability and homogenous dispersion. Stability Temperature up to 40°C: Pirenoxine Sodium stable up to 40°C is used in tropical drug storage applications, where it maintains chemical integrity and prolongs product shelf life. Melting Point 238°C: Pirenoxine Sodium with melting point 238°C is used in high-temperature sterilization processes, where it demonstrates thermal resistance and maintains efficacy. Water Solubility 2 mg/mL: Pirenoxine Sodium with water solubility 2 mg/mL is used in aqueous eye solutions, where it supports efficient drug delivery and optimal active concentration. Bulk Density 0.45 g/cm³: Pirenoxine Sodium with bulk density 0.45 g/cm³ is used in large-scale pharmaceutical blending, where it allows uniform mixing and controlled formulation flowability. Assay ≥98.5%: Pirenoxine Sodium with assay ≥98.5% is used in regulated ophthalmic drug production, where it ensures compliance with pharmacopeial standards and product safety. pH Range 6.8–7.4: Pirenoxine Sodium with pH range 6.8–7.4 is used in buffered ophthalmic preparations, where it ensures ocular compatibility and patient comfort. Residual Solvent <0.5%: Pirenoxine Sodium with residual solvent content less than 0.5% is used in parenteral eye injection formulations, where it minimizes toxicity risk and meets safety regulations. |
Competitive Pirenoxine Sodium prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As people age, eye health takes on new importance, especially for those facing the unsettling reality of lens opacities and vision loss. Pirenoxine Sodium stands out because it targets the clouding of the lens, a process that catches many people off guard. For decades, cataracts have forced millions to accept diminished sight or gamble with surgery. Instead of settling for limited options, patients now look for meaningful alternatives. Pirenoxine Sodium offers hope—based on chemistry and research, not empty promises or wishful thinking.
Many eye drops and so-called remedies clutter the pharmacy shelf. Few products have the backstory of Pirenoxine Sodium, which attracted attention in Japan and several other countries after researchers discovered its impact on lens proteins. In simple terms, the lenses in our eyes are kept clear by an orderly structure of proteins. Once this structure breaks down, clouds form, and vision grows dim and hazy. Environmental stress, sunlight, genetics, and poor metabolic health all push this process forward. Pirenoxine Sodium doesn’t promise to reverse blindness. Its power lies in slowing down or stopping these damaging changes. The science doesn’t lean on hype; clinical trials and long-term use in real clinics form the evidence.
It’s impossible to ignore the difference between Pirenoxine Sodium and everyday eye moisturizers or generic drops. Most eye products focus on simple relief: reducing dryness, washing away allergens, or soothing irritation. Their effects last a few hours, without challenging the underlying causes of vision decline. Pirenoxine Sodium moves beyond mere surface comfort. Researchers designed the compound to interact with the proteins that make up the lens, so it’s not just a surface moisturizer. Instead, daily use helps protect the structural health of the lens itself, slowing down the processes that turn it cloudy over months and years.
Pirenoxine Sodium appears as a fine white or off-white powder, stable and reliable under standard storage. The active compound dissolves easily in water, lending itself to accurate dosing in formulations. Many patients experience minimal irritation even when using it daily—a claim few chemical products can match. Among all the drugs introduced for eye care in the 20th century, Pirenoxine Sodium made it onto the World Health Organization’s list of essential medicines.
Many people ask about specifications, but in day-to-day life, few end users care about decimal points and manufacturing codes. More important is that every batch comes with transparency: packaging lists concentration and expiration, with clear directions for safe storage. No hidden preservatives or chemical agents surprise the user. Customers, especially older adults, don’t have time for ambiguity or afraid of burning sensations. Pirenoxine Sodium, as available from leading brands, respects that reality.
People use Pirenoxine Sodium mainly for controlling and delaying the clouding typical of cataracts. Although no eye drop presently replaces cataract surgery for the fully affected lens, Pirenoxine Sodium plays a leading role in countries where surgery is less accessible, or patients hope to keep their own lens for as long as possible. This makes it particularly valuable in resource-limited settings, where access to surgical equipment and skilled ophthalmologists remains an issue.
Some doctors recommend it to patients as soon as early signs of lens opacity appear, especially in adults who want to postpone surgery. Children find use in rare inherited forms of lens clouding, with careful guidance from doctors and pharmacies that source genuine formulations. People who struggle with frequent UV exposure—farmers, construction workers, outdoor athletes—appreciate anything that slows the relentless attack on their eyes. Even among people who prize “natural” approaches to health, Pirenoxine Sodium finds an audience, because its side-effect profile is light and tolerable after decades of use.
Not everyone notices an immediate improvement in sight. The science doesn’t support dramatic claims or overnight effects. Instead, regular users often report that their vision doesn’t worsen as quickly as before. Some say that midday glare or the “halo” effect from oncoming headlights bothers them less. For aging parents or grandparents who dread surgery, the possibility to keep driving, reading, or watching TV with less frustration can’t be underestimated. I think about my own grandmother—her routines and independence meant everything to her. She started using Pirenoxine Sodium once her ophthalmologist explained the process behind her cloudier vision. Though we knew it was not a cure-all, it granted her a few more years of comfort before she finally decided to face surgery.
Dosage follows strict guidelines: usually one to two drops in the affected eye, up to three times daily. Most brands craft single-use containers, so there’s less risk from contamination. These packages also help patients keep track of daily use, making it less likely anyone skips doses or wastes product through spoilage. The design reflects a broader trend in medicine, where patient compliance often matters more than miracle chemistry.
People hoping for a truly revolutionary drug for cataracts often turn to antioxidant supplements, herbal extracts, or treatments with bold claims online. Many of these alternatives lack strong evidence, and some even endanger users. I’ve seen friends and relatives try herbal blends, only to grow discouraged after months without results—or worse, suffer allergic reactions. Prescription lenses change vision temporarily but do nothing to halt the root cause. On the other hand, Pirenoxine Sodium keeps expectations honest. Nobody promises magic. Instead, users place trust in a clear mechanism: targeted prevention of lens protein clumping by a well-characterized molecule.
The reality is that rival pharmaceuticals like lanosterol-based drops or designer antioxidants remain experimental. They lack the official green lights from regulatory bodies and years of real-world observation. Surgery works efficiently, with a proven safety record, but economic and health barriers make it a last resort for many. Laser or other non-invasive procedures still don’t tackle the chemical reality inside lens cells. It’s not just about zapping away cloudiness; it’s about slowing it down at the source. Pirenoxine Sodium gives people the best option rooted in decades of careful research, not the latest clickbait trend.
Experienced eye doctors often review the science before recommending any drug for daily use. Pirenoxine Sodium clears this high bar, with a safety profile reviewed in rigorous clinical studies. Reports published in journals like Ophthalmology and Investigative Ophthalmology & Visual Science discuss its effects over many years of use. In my work with patient advocacy, I’ve seen how these research papers help skeptical patients gain trust. The fact that major health systems keep it on the approved drug lists shows that established experts value its benefits for specific cases. It’s not just for clinics in big cities; community health workers and pharmacists in rural regions also keep it stocked—often because local doctors and nurses have seen its steady results.
Another pillar of trust comes from the manufacturing process. Factories producing Pirenoxine Sodium must meet global standards on purity and batch consistency, which matters most for people with sensitive eyes. Authentic packs come with clear labeling, expiration dates, and easy-to-read instructions. Many regulatory agencies require disclosure of the source of manufacture, so customers know they’re not gambling on counterfeit goods. An eye drop doesn’t earn this trust by accident—it takes years of delivering on quality. For elderly users navigating a confusing marketplace of supplements and promises, these signs make all the difference.
Patients and doctors both carry responsibility regarding medication. Eye drops with Pirenoxine Sodium don’t serve everyone. Those with severe allergies to sulfa drugs or certain preservatives should avoid it, so honest communication with healthcare teams matters more than ever. It’s never wise to start or stop any eye medication without a thorough eye exam and professional advice. Local pharmacists know the risks and screen for potential drug interactions. Any marketing or commentary should stick to the science and never promise what evidence can’t support.
Some online sellers have tried to repackage Pirenoxine Sodium as the “miracle cure,” making bold statements about instantly restoring perfect eyesight. This crosses an ethical line and runs counter to my own values. People deserve straightforward data and measured hope, not risky hype. As someone involved in health writing and support groups, I’ve learned that honesty builds lasting trust. Doctors, too, want nothing more than tools that make a difference without false promises. Families dealing with age-related vision loss trust in things they can verify, not mysterious boxes or aggressive marketing.
Living with cataracts or early lens clouding comes with emotional weight. Many patients postpone appointments for fear of bad news, or they put off surgery because of worry about cost or recovery. Pirenoxine Sodium offers another chapter—a chance to act early and protect what remains of natural sight. Simple routines, like setting an alarm for daily drops or keeping a bottle at the office, help people stay ahead of the curve. For caregivers supporting older family members, these drops grant a real sense of agency. Nobody likes to feel powerless in the face of creeping vision loss.
Early intervention always beats waiting until symptoms become severe. If caught at an early stage, lens clouding doesn’t have to spell the end of reading, hobbies, or independent living. Even short delays in the need for surgery save families money and stress. Most health insurance systems still struggle to keep up with demand for cataract procedures, especially in fast-aging societies. Every extra year of useful sight means a year less spent on complex surgeries, long waits, and intensive aftercare. Pirenoxine Sodium fits into the toolkit for holding back those pressures, one drop at a time.
Up-and-coming research on lens biology and visual aging continues to explore new roads toward prevention. What sets Pirenoxine Sodium apart is not a secret recipe, but the open publication of its results and the clear pathway for building on early findings. Public health programs can raise awareness about preventable blindness by including reliable options for those most at risk. Regional outreach often means mobile clinics and educational campaigns, helping people avoid late diagnosis. Pirenoxine Sodium plays a steady role here, since healthcare workers can explain its use to rural elders or busy city dwellers.
Funding for more high-quality studies will help answer questions about the optimal age to start therapy, its long-term side effects in different populations, and how it can best complement other eye health strategies. Governments and charities that sponsor cataract relief projects have a stake in tools that stretch the impact of their limited budgets. Every time the scientific community validates another step in lens preservation, the case for Pirenoxine Sodium grows stronger.
Every eye patient faces a personal crossroads, where hopes for scientific progress weigh against the realities of daily life. Whether dealing with advancing age, a history of diabetes, or genetic risks, maintaining independence and clarity of sight becomes a major goal. Pirenoxine Sodium, with decades of patient experience and peer validation, carries more weight than passing trends.
My own experience helping family members through the ups and downs of vision loss has underscored the need for honest, lasting solutions. Watching loved ones struggle with blunt, one-size-fits-all treatments made me value products that aim for prevention, not just management after the fact. The difference Pirenoxine Sodium makes may sound modest at a glance, but a longer “active” life before surgery or severe loss adds up in real terms. While some may choose surgery when symptoms grow too severe, many cherish the chance to push that day back and keep participating fully in daily routines for longer. For them, Pirenoxine Sodium’s value is clear—no need for empty superlatives.
People deserve to make decisions based on facts and lived experience, not on glossy ads or empty promises. Pirenoxine Sodium has earned its place through slow, careful progress—an approach more companies and health leaders could learn from. Its real influence comes not only from chemistry but from the thousands of patients and clinicians who took a chance on something new decades ago and found enough benefit to keep it in regular use.
Eyesight shapes the way we interact with the world, and preserving it as long as possible should stay a priority. Pirenoxine Sodium can’t solve every problem or replace informed medical advice. It brings another layer of defense for people who want to fight vision loss on multiple fronts. By keeping expectations grounded and the science transparent, this product shows how modern medicine can respect both the complexities of biology and the practical needs of everyday life. Anyone searching for a clear, responsible next step in lens health will recognize the value Pirenoxine Sodium provides—rooted in evidence, not hope alone.